Jobes David A, Rizvi Shireen L
Department of Psychology, The Catholic University of America, Washington, DC, United States.
Graduate School of Applied and Professional Psychology, Rutgers University, Piscataway, NJ, United States.
Front Psychiatry. 2024 Jul 18;15:1354430. doi: 10.3389/fpsyt.2024.1354430. eCollection 2024.
Around the world, suicide ideation, attempts, and deaths pose a major public and mental health challenge for patients (and their loved ones). Accordingly, there is a clear need for effective clinical treatments that reliably reduce suicidal thoughts and behaviors. In this article, we review the Collaborative Assessment and Management of Suicidality (CAMS) and Dialectical Behavior Therapy (DBT), two clinical treatments that rise to the highest levels of empirical rigor. Both CAMS and DBT are now supported by randomized controlled trials (RCTs), with independent replications, and meta-analyses. There are also supportive data related to training clinical providers to use CAMS and DBT with adherence. RCTs that investigate the use of both interventions within clinical trial research designs and the increasing use of these complementary approaches within routine clinical practice are discussed. Future directions for research and clinical use of CAMS and DBT are explored as means to effectively treat suicidal risk.
在全球范围内,自杀意念、自杀未遂及自杀死亡给患者(及其亲人)带来了重大的公共卫生和心理健康挑战。因此,显然需要有效的临床治疗方法来可靠地减少自杀念头和行为。在本文中,我们回顾了自杀性评估与管理协作疗法(CAMS)和辩证行为疗法(DBT),这两种临床治疗方法达到了实证严谨性的最高水平。CAMS和DBT现在都有随机对照试验(RCT)的支持,包括独立重复试验和荟萃分析。也有关于培训临床提供者以依从性方式使用CAMS和DBT的支持性数据。本文讨论了在临床试验研究设计中对这两种干预措施使用情况的调查性RCT,以及在常规临床实践中对这些互补方法越来越多的使用情况。我们探索了CAMS和DBT在研究和临床应用方面的未来方向,作为有效治疗自杀风险的手段。